Özsoy-Ünübol Tuğba, Kullakçi Hakan, Ilhan İrem, Yilmaz Figen
Department of Physical Medicine and Rehabilitation, Sultan Abdulhamid Han Training and Research Hospital, Istanbul, Turkey.
Department of Psychiatry, Sultan Abdulhamid Han Training and Research Hospital, Istanbul, Turkey.
Arch Rheumatol. 2020 Mar 26;35(4):584-591. doi: 10.46497/ArchRheumatol.2020.7833. eCollection 2020 Dec.
This study aims to evaluate smell and taste functions in patients with fibromyalgia syndrome (FMS) and the relationship between smell and taste functions, anxiety, depression, alexithymia, and quality of life (QoL).
This cross-sectional study included 30 patients with FMS (3 males, 27 females; mean age 46.0±8.5 years; range, 18 to 70 years) and 20 age- and sex-matched healthy participants (2 males, 18 females; mean age 45.7±10.0 years; range, 18 to 70 years). Fibromyalgia Impact Questionnaire (FIQ) was applied to FMS patients. Hamilton Anxiety Scale, Depression Scale, Toronto Alexithymia Scale, and EuroQol Questionnaire Five-Dimensions (EQ-5D) were applied to all participants. Sniffin' Sticks test was used for olfactory function analysis while taste strips were used for gustatory function analysis.
The FMS patients had higher anxiety, depression, and alexithymia while lower QoL scores. Olfactory and gustatory function test scores were lower in FMS patients. Total olfactory function scores were 25.96 and 36.40 for FMS and control groups, respectively. For taste function, they were 9.93 and 13.55, respectively. These scores were negatively correlated with anxiety, depression, and alexithymia scores whereas positively correlated with EQ-5D index score. There was no significant correlation with FIQ score.
Anxiety and depression are common symptoms of FMS. Patients with FMS had altered olfactory and gustatory functions and these impairments were correlated with their anxiety and depression. Further studies with larger sample sizes including functional magnetic resonance imaging evaluation should be performed.
本研究旨在评估纤维肌痛综合征(FMS)患者的嗅觉和味觉功能,以及嗅觉和味觉功能、焦虑、抑郁、述情障碍与生活质量(QoL)之间的关系。
这项横断面研究纳入了30例FMS患者(3例男性,27例女性;平均年龄46.0±8.5岁;范围18至70岁)和20名年龄及性别匹配的健康参与者(2例男性,18例女性;平均年龄45.7±10.0岁;范围18至70岁)。对FMS患者应用纤维肌痛影响问卷(FIQ)。对所有参与者应用汉密尔顿焦虑量表、抑郁量表、多伦多述情障碍量表和欧洲生活质量五维度问卷(EQ-5D)。使用嗅觉棒测试进行嗅觉功能分析,同时使用味觉试纸进行味觉功能分析。
FMS患者的焦虑、抑郁和述情障碍得分较高,而生活质量得分较低。FMS患者的嗅觉和味觉功能测试得分较低。FMS组和对照组的总嗅觉功能得分分别为25.96和36.40。对于味觉功能,分别为9.93和13.55。这些得分与焦虑、抑郁和述情障碍得分呈负相关,而与EQ-5D指数得分呈正相关。与FIQ得分无显著相关性。
焦虑和抑郁是FMS的常见症状。FMS患者的嗅觉和味觉功能发生改变,这些损害与他们的焦虑和抑郁相关。应进行更大样本量的进一步研究,包括功能磁共振成像评估。